Diabetic dermopathy and internal complications in diabetes mellitus

International Journal of Dermatology
A ShemerR Friedman-Birnbaum

Abstract

Diabetic dermopathy is the most common cutaneous marker of diabetes mellitus. The relationship of diabetic dermopathy to internal complications of diabetes mellitus, such as nephropathy, retinopathy, and neuropathy, is still unknown. The possible role of diabetic dermopathy as a clinical sign of internal complications in diabetes mellitus was investigated. One hundred and seventy-three patients with diabetes mellitus, of whom 125 (72%) had insulin-dependent diabetes mellitus and 48 (28%) had non-insulin-dependent diabetes mellitus, were studied. Diabetic dermopathy was present in 69 (40%) of patients, statistically more significant in patients 50 years of age and older. The mean diabetic duration was significantly higher in patients with diabetic dermopathy than in those without. The associations of diabetic dermopathy with retinopathy, nephropathy, and neuropathy were each statistically significant, and the increased frequency of diabetic dermopathy correlated with an increased number of these three complications in each patient. Some of the factors that affect the development of internal complications in diabetes mellitus may play a role in the development of diabetic dermopathy, and diabetic dermopathy may serve as a clinica...Continue Reading

Citations

Aug 21, 2013·Indian Journal of Endocrinology and Metabolism·Roshni VahoraYogesh Marfatia
Oct 19, 2013·American Journal of Clinical Dermatology·Duriye Deniz DemirserenBekir Cakır
May 30, 2013·Indian Journal of Dermatology·Xinhong GeJianzhong Zhang
Nov 30, 2013·Endocrinology and Metabolism Clinics of North America·Blair Murphy-ChutorianSteven R Cohen
Jul 31, 2012·Pathology, Research and Practice·Tatiana Elias ColomboMargarete Teresa Gottardo de Almeida
May 3, 2011·Journal of the American Academy of Dermatology·Alexandra BruglerMarc Rendell
Dec 25, 2007·Journal of the American Academy of Dermatology·Aaron Joseph Morgan, Robert A Schwartz
Oct 25, 2006·The Nursing Clinics of North America·Marjorie Cypress, Donna Tomky
Dec 24, 2003·Journal of Cutaneous Pathology·Gregory M Houck, Michael B Morgan
Aug 19, 2011·Journal of Diabetes·Lauren Levy, Joshua A Zeichner
Oct 19, 2013·International Journal of Dermatology·Mohammad Afkhami-ArdekaniNeda Zaji
Mar 17, 2004·Dermatologic Clinics·Joseph Brant Schneider, Robert A Norman
Feb 22, 2012·Nutrition·Hassan I El-SayyadAhmed S Yonis
Oct 11, 2014·Diabetes Technology & Therapeutics·Malgorzata Mackiewicz-WysockaDorota Zozulinska-Ziolkiewicz
Sep 7, 2016·MMW Fortschritte der Medizin·Tanja de Béchade, Kilian Eyerich
Nov 7, 2016·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·G HolzerB Volc-Platzer
Feb 23, 2017·Anais Brasileiros De Dermatologia·Adriana Lucia MendesVidal Haddad
Sep 25, 2018·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Aurora ParodiLeonardo Zichichi
Aug 3, 2005·American Journal of Clinical Dermatology·Binh T NgoMarc S Rendell
Aug 16, 2002·American Journal of Clinical Dermatology·Mo Aye, Ewan A Masson
Mar 22, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Y Richard Wang, David Margolis
Jun 6, 2009·Postgraduate Medicine·Yehia Y Mishriki
Jul 19, 2011·The Journal of Dermatology·Samuel McCash, Patrick O Emanuel
Aug 5, 2010·Ciência & saúde coletiva·Adriana Novaes RodriguesJozias de Andrade Sobrinho
Dec 17, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Piyu Parth Naik, Syed Nadir Farrukh
Jan 12, 2021·Journal of Lasers in Medical Sciences·Nermeen Mohamed AbdelhalimAhmed Fathy Samhan
Jun 2, 2021·The Medical Clinics of North America·Alex HinesMark D P Davis
Aug 13, 2002·Dermatologic Clinics·Tammie Ferringer, Fred Miller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.